BCAL DIAGNOSTICS LIMITED
ASX:BDXPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 94.2% of what they think they own, once every option and right converts.
Runway 4–8 quarters; 1 cash raise in 24 months; options/rights overhang 6% of shares
BCAL DIAGNOSTICS LIMITED's ordinary share count was 369M as of March 2026, up 2.8% since September 2024. One capital raise occurred in the 24-month window: a Convertible Note Facility in October 2025 raising A$10.0M. Options and rights on issue could convert into 23M new shares, representing a 6.1% overhang; 1% of shares are in the money, and the nearest expiry is October 2027. The company holds more than 4 quarters of funding at the recent spend rate as of its June 2026 quarter. No proposed securities issues are pending.
Quick answers · 4
When did BDX last raise capital?
The last capital raise in Bcal Diagnostics's filings is Convertible Note Facility of $10.0M announced 21 Oct 2025, one of 1 cash raises in 24 months.
How much cash does BDX have?
In its quarterly cash report for the quarter ended 30 June 2026, Bcal Diagnostics reported $1.6M of cash and estimated 2.6 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do BDX's options expire?
Unexercised options and rights equal 6.1% of Bcal Diagnostics's shares on issue; the nearest expiry is Oct 2027.
How much has BDX's share count grown?
Bcal Diagnostics has 368.7M shares on issue as at 28 Oct 2026, up 2.8% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 25 Aug 2026 | 3G · unquoted | ORDINARY FULLY PAID | 368.7M | Appendix 3G |
| 21 Aug 2026 | 3G · unquoted | BDX : ORDINARY FULLY PAID | 368.7M | Appendix 3G |
| 14 July 2026 | 3G · unquoted | BDX : ORDINARY FULLY PAID | 368.7M | Appendix 3G |
| 14 July 2026 | 3G · unquoted | BDX : ORDINARY FULLY PAID | 368.7M | Appendix 3G |
| 14 July 2026 | 3G · unquoted | BDX : ORDINARY FULLY PAID | 368.7M | Appendix 3G |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
1 cash raise in the last 24 months · 0 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered15.5M · 4.2% of sharesOptions and warrants — they convert when the share price clears their exercise price.
- Condition-triggered7.1M · 1.9% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 15.5M priced (of which 3.5M in the money), 7.1M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
At $0.080 today, 3.5M securities are in the money (0.9% of shares on issue). No more priced supply until 5× today’s price, which takes it to 15.5M (4.2% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 7.1M (31.3% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| BDXAH | Options | Price-triggered | $0.25 | 8 Oct 2027 | 12.0M | Filing |
| BDXAD | Options | Price-triggered | $0.057 | 20 Nov 2029 | 3.5M | Filing |
| BDXAF | Performance rights | Condition-triggered | — | — | 7.1M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
- BDXAIconvertible notes7.6M25 Aug 2026 Appendix 2A
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 19 Mar 2026 | Jayne Shaw | Buy on-market | 225k | 2.0M | — | $22k | 3Y notice |
| 18 Mar 2026 | Jayne Shaw | Buy on-market | — | 2.0M | — | $8k | 3Y notice |
| 16 Mar 2026 | Jayne Shaw | Buy on-market | 300k | 2.0M | — | $29k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.